nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—HSP90AA1—larynx—head and neck cancer	0.0457	0.131	CbGeAlD
Rifabutin—HSP90B1—exocrine gland—head and neck cancer	0.0259	0.0741	CbGeAlD
Rifabutin—HSP90B1—hair follicle—head and neck cancer	0.0247	0.0706	CbGeAlD
Rifabutin—HSP90B1—mouth—head and neck cancer	0.0194	0.0554	CbGeAlD
Rifabutin—HSP90AA1—exocrine gland—head and neck cancer	0.019	0.0542	CbGeAlD
Rifabutin—HSP90AA1—hair follicle—head and neck cancer	0.0181	0.0516	CbGeAlD
Rifabutin—HSP90B1—neck—head and neck cancer	0.0166	0.0474	CbGeAlD
Rifabutin—HSP90AA1—mouth—head and neck cancer	0.0142	0.0405	CbGeAlD
Rifabutin—HSP90B1—parotid gland—head and neck cancer	0.0135	0.0386	CbGeAlD
Rifabutin—HSP90B1—saliva-secreting gland—head and neck cancer	0.0129	0.0369	CbGeAlD
Rifabutin—Emotional distress—Hydroxyurea—head and neck cancer	0.0128	0.0494	CcSEcCtD
Rifabutin—HSP90AA1—neck—head and neck cancer	0.0121	0.0346	CbGeAlD
Rifabutin—HSP90B1—connective tissue—head and neck cancer	0.0119	0.034	CbGeAlD
Rifabutin—HSP90B1—epithelium—head and neck cancer	0.0113	0.0322	CbGeAlD
Rifabutin—Congenital anomaly—Fluorouracil—head and neck cancer	0.0103	0.0398	CcSEcCtD
Rifabutin—Developmental delay—Fluorouracil—head and neck cancer	0.0103	0.0398	CcSEcCtD
Rifabutin—HSP90B1—trachea—head and neck cancer	0.00998	0.0285	CbGeAlD
Rifabutin—HSP90AA1—parotid gland—head and neck cancer	0.00987	0.0282	CbGeAlD
Rifabutin—HSP90AA1—saliva-secreting gland—head and neck cancer	0.00946	0.027	CbGeAlD
Rifabutin—Gastrointestinal symptom NOS—Hydroxyurea—head and neck cancer	0.00925	0.0357	CcSEcCtD
Rifabutin—Emotional distress—Fluorouracil—head and neck cancer	0.0092	0.0355	CcSEcCtD
Rifabutin—Platelet count decreased—Hydroxyurea—head and neck cancer	0.00914	0.0353	CcSEcCtD
Rifabutin—HSP90AA1—connective tissue—head and neck cancer	0.00869	0.0248	CbGeAlD
Rifabutin—HSP90B1—lymphoid tissue—head and neck cancer	0.00869	0.0248	CbGeAlD
Rifabutin—HSP90AA1—epithelium—head and neck cancer	0.00825	0.0236	CbGeAlD
Rifabutin—HSP90B1—thyroid gland—head and neck cancer	0.00789	0.0225	CbGeAlD
Rifabutin—HSP90AA1—trachea—head and neck cancer	0.00729	0.0208	CbGeAlD
Rifabutin—HSP90B1—head—head and neck cancer	0.007	0.02	CbGeAlD
Rifabutin—Gastrointestinal symptom NOS—Fluorouracil—head and neck cancer	0.00665	0.0257	CcSEcCtD
Rifabutin—HSP90AA1—lymphoid tissue—head and neck cancer	0.00635	0.0182	CbGeAlD
Rifabutin—HSP90AA1—thyroid gland—head and neck cancer	0.00577	0.0165	CbGeAlD
Rifabutin—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.00575	0.0222	CcSEcCtD
Rifabutin—Lymphopenia—Docetaxel—head and neck cancer	0.00552	0.0213	CcSEcCtD
Rifabutin—HSP90AA1—head—head and neck cancer	0.00512	0.0146	CbGeAlD
Rifabutin—HSP90B1—lymph node—head and neck cancer	0.0049	0.014	CbGeAlD
Rifabutin—HSP90AA1—lymph node—head and neck cancer	0.00358	0.0102	CbGeAlD
Rifabutin—Pancytopenia—Vinblastine—head and neck cancer	0.00355	0.0137	CcSEcCtD
Rifabutin—Pancytopenia—Hydroxyurea—head and neck cancer	0.00324	0.0125	CcSEcCtD
Rifabutin—Chest discomfort—Docetaxel—head and neck cancer	0.00319	0.0123	CcSEcCtD
Rifabutin—Neutropenia—Hydroxyurea—head and neck cancer	0.00319	0.0123	CcSEcCtD
Rifabutin—Agranulocytosis—Vinblastine—head and neck cancer	0.00311	0.012	CcSEcCtD
Rifabutin—Blood bilirubin increased—Docetaxel—head and neck cancer	0.00299	0.0115	CcSEcCtD
Rifabutin—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00288	0.0111	CcSEcCtD
Rifabutin—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00282	0.0109	CcSEcCtD
Rifabutin—Eosinophilia—Fluorouracil—head and neck cancer	0.00243	0.00939	CcSEcCtD
Rifabutin—Anaemia—Vinblastine—head and neck cancer	0.00241	0.0093	CcSEcCtD
Rifabutin—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00236	0.0091	CcSEcCtD
Rifabutin—Leukopenia—Vinblastine—head and neck cancer	0.00233	0.00901	CcSEcCtD
Rifabutin—Pancytopenia—Fluorouracil—head and neck cancer	0.00233	0.009	CcSEcCtD
Rifabutin—Convulsion—Vinblastine—head and neck cancer	0.00226	0.00872	CcSEcCtD
Rifabutin—Anaemia—Hydroxyurea—head and neck cancer	0.0022	0.00848	CcSEcCtD
Rifabutin—Leukopenia—Hydroxyurea—head and neck cancer	0.00213	0.00821	CcSEcCtD
Rifabutin—Thrombocytopenia—Vinblastine—head and neck cancer	0.00208	0.00804	CcSEcCtD
Rifabutin—Convulsion—Hydroxyurea—head and neck cancer	0.00206	0.00795	CcSEcCtD
Rifabutin—Agranulocytosis—Fluorouracil—head and neck cancer	0.00204	0.00789	CcSEcCtD
Rifabutin—Anorexia—Vinblastine—head and neck cancer	0.00203	0.00783	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00201	0.00776	CcSEcCtD
Rifabutin—Paraesthesia—Vinblastine—head and neck cancer	0.00191	0.00737	CcSEcCtD
Rifabutin—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.0019	0.00733	CcSEcCtD
Rifabutin—Skin disorder—Hydroxyurea—head and neck cancer	0.00188	0.00728	CcSEcCtD
Rifabutin—CYP1A2—thyroid gland—head and neck cancer	0.00187	0.00533	CbGeAlD
Rifabutin—Anorexia—Hydroxyurea—head and neck cancer	0.00185	0.00714	CcSEcCtD
Rifabutin—Decreased appetite—Vinblastine—head and neck cancer	0.00185	0.00714	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00185	0.00713	CcSEcCtD
Rifabutin—Pain—Vinblastine—head and neck cancer	0.00182	0.00702	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00181	0.00698	CcSEcCtD
Rifabutin—Feeling abnormal—Vinblastine—head and neck cancer	0.00175	0.00677	CcSEcCtD
Rifabutin—Bronchospasm—Docetaxel—head and neck cancer	0.00174	0.00673	CcSEcCtD
Rifabutin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00174	0.00672	CcSEcCtD
Rifabutin—Dyspnoea—Hydroxyurea—head and neck cancer	0.00173	0.00668	CcSEcCtD
Rifabutin—Dyspepsia—Hydroxyurea—head and neck cancer	0.00171	0.00659	CcSEcCtD
Rifabutin—Decreased appetite—Hydroxyurea—head and neck cancer	0.00169	0.00651	CcSEcCtD
Rifabutin—Pancytopenia—Docetaxel—head and neck cancer	0.00168	0.0065	CcSEcCtD
Rifabutin—Abdominal pain—Vinblastine—head and neck cancer	0.00168	0.00649	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00167	0.00647	CcSEcCtD
Rifabutin—Pain—Hydroxyurea—head and neck cancer	0.00166	0.00641	CcSEcCtD
Rifabutin—Neutropenia—Docetaxel—head and neck cancer	0.00166	0.0064	CcSEcCtD
Rifabutin—Feeling abnormal—Hydroxyurea—head and neck cancer	0.0016	0.00617	CcSEcCtD
Rifabutin—Anaemia—Fluorouracil—head and neck cancer	0.00158	0.00611	CcSEcCtD
Rifabutin—Hypersensitivity—Vinblastine—head and neck cancer	0.00157	0.00605	CcSEcCtD
Rifabutin—Jaundice—Docetaxel—head and neck cancer	0.00154	0.00595	CcSEcCtD
Rifabutin—Body temperature increased—Hydroxyurea—head and neck cancer	0.00153	0.00592	CcSEcCtD
Rifabutin—Leukopenia—Fluorouracil—head and neck cancer	0.00153	0.00591	CcSEcCtD
Rifabutin—Asthenia—Vinblastine—head and neck cancer	0.00153	0.00589	CcSEcCtD
Rifabutin—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00149	0.00577	CcSEcCtD
Rifabutin—Convulsion—Fluorouracil—head and neck cancer	0.00148	0.00572	CcSEcCtD
Rifabutin—Agranulocytosis—Docetaxel—head and neck cancer	0.00147	0.00569	CcSEcCtD
Rifabutin—HSP90AA1—Regulation of actin dynamics for phagocytic cup formation—MAPK1—head and neck cancer	0.00147	0.00375	CbGpPWpGaD
Rifabutin—Chest pain—Fluorouracil—head and neck cancer	0.00146	0.00562	CcSEcCtD
Rifabutin—Myalgia—Fluorouracil—head and neck cancer	0.00146	0.00562	CcSEcCtD
Rifabutin—Diarrhoea—Vinblastine—head and neck cancer	0.00146	0.00562	CcSEcCtD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—IL2—head and neck cancer	0.00143	0.00366	CbGpPWpGaD
Rifabutin—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00143	0.00552	CcSEcCtD
Rifabutin—HSP90AA1—Integrins in angiogenesis—MAPK3—head and neck cancer	0.00142	0.00364	CbGpPWpGaD
Rifabutin—HSP90AA1—Class I PI3K signaling events—HRAS—head and neck cancer	0.00142	0.00364	CbGpPWpGaD
Rifabutin—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.00142	0.00363	CbGpPWpGaD
Rifabutin—Hepatitis—Docetaxel—head and neck cancer	0.00142	0.00548	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CCNA1—head and neck cancer	0.00141	0.00362	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—head and neck cancer	0.00141	0.00362	CbGpPWpGaD
Rifabutin—Confusional state—Fluorouracil—head and neck cancer	0.00141	0.00544	CcSEcCtD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.0014	0.00357	CbGpPWpGaD
Rifabutin—Connective tissue disorder—Docetaxel—head and neck cancer	0.00139	0.00538	CcSEcCtD
Rifabutin—Asthenia—Hydroxyurea—head and neck cancer	0.00139	0.00537	CcSEcCtD
Rifabutin—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00137	0.00528	CcSEcCtD
Rifabutin—HSP90AA1—Integrins in angiogenesis—MAPK1—head and neck cancer	0.00135	0.00346	CbGpPWpGaD
Rifabutin—Vomiting—Vinblastine—head and neck cancer	0.00135	0.00522	CcSEcCtD
Rifabutin—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—MAPK3—head and neck cancer	0.00134	0.00342	CbGpPWpGaD
Rifabutin—HSP90AA1—Regulation of Telomerase—MAPK3—head and neck cancer	0.00134	0.00342	CbGpPWpGaD
Rifabutin—Headache—Vinblastine—head and neck cancer	0.00133	0.00515	CcSEcCtD
Rifabutin—Anorexia—Fluorouracil—head and neck cancer	0.00133	0.00514	CcSEcCtD
Rifabutin—Diarrhoea—Hydroxyurea—head and neck cancer	0.00133	0.00512	CcSEcCtD
Rifabutin—Eye disorder—Docetaxel—head and neck cancer	0.00133	0.00512	CcSEcCtD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—IL2—head and neck cancer	0.00131	0.00334	CbGpPWpGaD
Rifabutin—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.0013	0.00334	CbGpPWpGaD
Rifabutin—Immune system disorder—Docetaxel—head and neck cancer	0.00128	0.00495	CcSEcCtD
Rifabutin—HSP90AA1—Regulation of Telomerase—MAPK1—head and neck cancer	0.00127	0.00325	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—MAPK1—head and neck cancer	0.00127	0.00325	CbGpPWpGaD
Rifabutin—HSP90AA1—Regulation of Telomerase—EGFR—head and neck cancer	0.00127	0.00325	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00127	0.00491	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle—CCNA1—head and neck cancer	0.00126	0.00323	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—UROD—head and neck cancer	0.00126	0.00323	CbGpPWpGaD
Rifabutin—Nausea—Vinblastine—head and neck cancer	0.00126	0.00488	CcSEcCtD
Rifabutin—Insomnia—Fluorouracil—head and neck cancer	0.00126	0.00488	CcSEcCtD
Rifabutin—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.00126	0.00321	CbGpPWpGaD
Rifabutin—HSP90AA1—Integrin-linked kinase signaling—AKT1—head and neck cancer	0.00126	0.00321	CbGpPWpGaD
Rifabutin—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00125	0.00321	CbGpPWpGaD
Rifabutin—Paraesthesia—Fluorouracil—head and neck cancer	0.00125	0.00484	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—BCL2L1—head and neck cancer	0.00125	0.00319	CbGpPWpGaD
Rifabutin—Dyspnoea—Fluorouracil—head and neck cancer	0.00124	0.00481	CcSEcCtD
Rifabutin—Vomiting—Hydroxyurea—head and neck cancer	0.00123	0.00476	CcSEcCtD
Rifabutin—Dyspepsia—Fluorouracil—head and neck cancer	0.00123	0.00475	CcSEcCtD
Rifabutin—Rash—Hydroxyurea—head and neck cancer	0.00122	0.00472	CcSEcCtD
Rifabutin—Dermatitis—Hydroxyurea—head and neck cancer	0.00122	0.00472	CcSEcCtD
Rifabutin—Headache—Hydroxyurea—head and neck cancer	0.00122	0.00469	CcSEcCtD
Rifabutin—Decreased appetite—Fluorouracil—head and neck cancer	0.00121	0.00469	CcSEcCtD
Rifabutin—Dysgeusia—Docetaxel—head and neck cancer	0.00121	0.00467	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00121	0.00465	CcSEcCtD
Rifabutin—Pain—Fluorouracil—head and neck cancer	0.00119	0.00461	CcSEcCtD
Rifabutin—HSP90AA1—Integrins in angiogenesis—PIK3CA—head and neck cancer	0.00117	0.003	CbGpPWpGaD
Rifabutin—HSP90AA1—Fcgamma receptor (FCGR) dependent phagocytosis—MAPK3—head and neck cancer	0.00116	0.00297	CbGpPWpGaD
Rifabutin—Nausea—Hydroxyurea—head and neck cancer	0.00115	0.00445	CcSEcCtD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—MAPK3—head and neck cancer	0.00115	0.00294	CbGpPWpGaD
Rifabutin—Feeling abnormal—Fluorouracil—head and neck cancer	0.00115	0.00444	CcSEcCtD
Rifabutin—Anaemia—Docetaxel—head and neck cancer	0.00114	0.00441	CcSEcCtD
Rifabutin—HSP90AA1—Fcgamma receptor (FCGR) dependent phagocytosis—MAPK1—head and neck cancer	0.00111	0.00283	CbGpPWpGaD
Rifabutin—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.00111	0.00283	CbGpPWpGaD
Rifabutin—Leukopenia—Docetaxel—head and neck cancer	0.00111	0.00427	CcSEcCtD
Rifabutin—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—PIK3CA—head and neck cancer	0.0011	0.00282	CbGpPWpGaD
Rifabutin—Body temperature increased—Fluorouracil—head and neck cancer	0.0011	0.00426	CcSEcCtD
Rifabutin—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.0011	0.00282	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—MAPK1—head and neck cancer	0.0011	0.0028	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—STAT6—head and neck cancer	0.0011	0.0028	CbGpPWpGaD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—VEGFA—head and neck cancer	0.00109	0.00279	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—SOD2—head and neck cancer	0.00108	0.00276	CbGpPWpGaD
Rifabutin—Convulsion—Docetaxel—head and neck cancer	0.00107	0.00413	CcSEcCtD
Rifabutin—Chest pain—Docetaxel—head and neck cancer	0.00105	0.00406	CcSEcCtD
Rifabutin—Arthralgia—Docetaxel—head and neck cancer	0.00105	0.00406	CcSEcCtD
Rifabutin—Myalgia—Docetaxel—head and neck cancer	0.00105	0.00406	CcSEcCtD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—MAPK3—head and neck cancer	0.00105	0.00269	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—MAPK3—head and neck cancer	0.00105	0.00269	CbGpPWpGaD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00104	0.00403	CcSEcCtD
Rifabutin—HSP90AA1—Cellular responses to stress—GPX1—head and neck cancer	0.00103	0.00263	CbGpPWpGaD
Rifabutin—Hypersensitivity—Fluorouracil—head and neck cancer	0.00103	0.00397	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—CASP8—head and neck cancer	0.00102	0.00261	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—RAD51—head and neck cancer	0.00102	0.0026	CbGpPWpGaD
Rifabutin—Confusional state—Docetaxel—head and neck cancer	0.00102	0.00392	CcSEcCtD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—MAPK1—head and neck cancer	0.000999	0.00256	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—MAPK1—head and neck cancer	0.000999	0.00256	CbGpPWpGaD
Rifabutin—Shock—Docetaxel—head and neck cancer	0.000991	0.00383	CcSEcCtD
Rifabutin—Pruritus—Fluorouracil—head and neck cancer	0.000988	0.00381	CcSEcCtD
Rifabutin—Thrombocytopenia—Docetaxel—head and neck cancer	0.000987	0.00381	CcSEcCtD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—VEGFA—head and neck cancer	0.000984	0.00252	CbGpPWpGaD
Rifabutin—Skin disorder—Docetaxel—head and neck cancer	0.000979	0.00378	CcSEcCtD
Rifabutin—Anorexia—Docetaxel—head and neck cancer	0.00096	0.00371	CcSEcCtD
Rifabutin—HSP90AA1—Fcgamma receptor (FCGR) dependent phagocytosis—PIK3CA—head and neck cancer	0.00096	0.00246	CbGpPWpGaD
Rifabutin—HSP90AA1—Integrins in angiogenesis—AKT1—head and neck cancer	0.000959	0.00245	CbGpPWpGaD
Rifabutin—Diarrhoea—Fluorouracil—head and neck cancer	0.000955	0.00369	CcSEcCtD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—TP53—head and neck cancer	0.000948	0.00242	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—MAPK3—head and neck cancer	0.000931	0.00238	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—VEGFA—head and neck cancer	0.000929	0.00237	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—TP53—head and neck cancer	0.00092	0.00235	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000918	0.00355	CcSEcCtD
Rifabutin—Insomnia—Docetaxel—head and neck cancer	0.000911	0.00352	CcSEcCtD
Rifabutin—Paraesthesia—Docetaxel—head and neck cancer	0.000905	0.00349	CcSEcCtD
Rifabutin—HSP90AA1—Regulation of Telomerase—AKT1—head and neck cancer	0.000902	0.00231	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—head and neck cancer	0.000902	0.00231	CbGpPWpGaD
Rifabutin—Dyspnoea—Docetaxel—head and neck cancer	0.000898	0.00347	CcSEcCtD
Rifabutin—Vomiting—Fluorouracil—head and neck cancer	0.000888	0.00343	CcSEcCtD
Rifabutin—Dyspepsia—Docetaxel—head and neck cancer	0.000887	0.00343	CcSEcCtD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—MAPK1—head and neck cancer	0.000886	0.00226	CbGpPWpGaD
Rifabutin—Rash—Fluorouracil—head and neck cancer	0.00088	0.0034	CcSEcCtD
Rifabutin—Dermatitis—Fluorouracil—head and neck cancer	0.000879	0.0034	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by VEGF—MAPK3—head and neck cancer	0.000879	0.00225	CbGpPWpGaD
Rifabutin—Decreased appetite—Docetaxel—head and neck cancer	0.000876	0.00338	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—BCL2—head and neck cancer	0.000875	0.00224	CbGpPWpGaD
Rifabutin—Headache—Fluorouracil—head and neck cancer	0.000875	0.00338	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00087	0.00336	CcSEcCtD
Rifabutin—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000868	0.00222	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000868	0.00222	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000868	0.00222	CbGpPWpGaD
Rifabutin—Pain—Docetaxel—head and neck cancer	0.000862	0.00333	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by VEGF—MAPK1—head and neck cancer	0.000836	0.00214	CbGpPWpGaD
Rifabutin—Feeling abnormal—Docetaxel—head and neck cancer	0.00083	0.00321	CcSEcCtD
Rifabutin—Nausea—Fluorouracil—head and neck cancer	0.000829	0.0032	CcSEcCtD
Rifabutin—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000824	0.00318	CcSEcCtD
Rifabutin—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00082	0.0021	CbGpPWpGaD
Rifabutin—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000812	0.00208	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—HRAS—head and neck cancer	0.000802	0.00205	CbGpPWpGaD
Rifabutin—Body temperature increased—Docetaxel—head and neck cancer	0.000797	0.00308	CcSEcCtD
Rifabutin—Abdominal pain—Docetaxel—head and neck cancer	0.000797	0.00308	CcSEcCtD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—HRAS—head and neck cancer	0.000789	0.00202	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—PTEN—head and neck cancer	0.000778	0.00199	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—AKT1—head and neck cancer	0.000777	0.00199	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—PIK3CA—head and neck cancer	0.000769	0.00197	CbGpPWpGaD
Rifabutin—Hypersensitivity—Docetaxel—head and neck cancer	0.000742	0.00287	CcSEcCtD
Rifabutin—HSP90B1—Immune System—BCL2L1—head and neck cancer	0.000726	0.00186	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—PIK3CA—head and neck cancer	0.000725	0.00185	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—PTEN—head and neck cancer	0.000725	0.00185	CbGpPWpGaD
Rifabutin—Asthenia—Docetaxel—head and neck cancer	0.000723	0.00279	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—PTEN—head and neck cancer	0.000715	0.00183	CbGpPWpGaD
Rifabutin—Pruritus—Docetaxel—head and neck cancer	0.000713	0.00275	CcSEcCtD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—HRAS—head and neck cancer	0.000711	0.00182	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—AKT1—head and neck cancer	0.000708	0.00181	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—AKT1—head and neck cancer	0.000708	0.00181	CbGpPWpGaD
Rifabutin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000702	0.00179	CbGpPWpGaD
Rifabutin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000693	0.00177	CbGpPWpGaD
Rifabutin—Diarrhoea—Docetaxel—head and neck cancer	0.000689	0.00266	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—TYMS—head and neck cancer	0.000683	0.00175	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—HRAS—head and neck cancer	0.000671	0.00172	CbGpPWpGaD
Rifabutin—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.00067	0.00171	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—MAPK3—head and neck cancer	0.000665	0.0017	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000645	0.00165	CbGpPWpGaD
Rifabutin—Vomiting—Docetaxel—head and neck cancer	0.000641	0.00247	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—STAT6—head and neck cancer	0.000638	0.00163	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000637	0.00163	CbGpPWpGaD
Rifabutin—Rash—Docetaxel—head and neck cancer	0.000635	0.00245	CcSEcCtD
Rifabutin—Dermatitis—Docetaxel—head and neck cancer	0.000635	0.00245	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—MAPK1—head and neck cancer	0.000632	0.00162	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—EGFR—head and neck cancer	0.000632	0.00162	CbGpPWpGaD
Rifabutin—Headache—Docetaxel—head and neck cancer	0.000631	0.00244	CcSEcCtD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—AKT1—head and neck cancer	0.000628	0.00161	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—MAPK3—head and neck cancer	0.000619	0.00158	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—MAPK3—head and neck cancer	0.000611	0.00156	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—TYMS—head and neck cancer	0.00061	0.00156	CbGpPWpGaD
Rifabutin—Nausea—Docetaxel—head and neck cancer	0.000598	0.00231	CcSEcCtD
Rifabutin—HSP90B1—Immune System—CASP8—head and neck cancer	0.000594	0.00152	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—AKT1—head and neck cancer	0.000593	0.00152	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—MAPK1—head and neck cancer	0.000589	0.00151	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—EGFR—head and neck cancer	0.000589	0.00151	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CDH1—head and neck cancer	0.000587	0.0015	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—MAPK1—head and neck cancer	0.000582	0.00149	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—EGFR—head and neck cancer	0.000581	0.00149	CbGpPWpGaD
Rifabutin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000569	0.00145	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—PIK3CA—head and neck cancer	0.000549	0.0014	CbGpPWpGaD
Rifabutin—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000545	0.00139	CbGpPWpGaD
Rifabutin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000542	0.00138	CbGpPWpGaD
Rifabutin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000535	0.00137	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—NAT2—head and neck cancer	0.000525	0.00134	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000516	0.00132	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KISS1—head and neck cancer	0.000516	0.00132	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—PIK3CA—head and neck cancer	0.000511	0.00131	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—BCL2—head and neck cancer	0.00051	0.0013	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—HRAS—head and neck cancer	0.000508	0.0013	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—PIK3CA—head and neck cancer	0.000505	0.00129	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000498	0.00127	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—NOTCH1—head and neck cancer	0.000495	0.00127	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000491	0.00126	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—BCL2L1—head and neck cancer	0.000487	0.00125	CbGpPWpGaD
Rifabutin—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000483	0.00123	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000478	0.00122	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—VEGFA—head and neck cancer	0.000478	0.00122	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—HRAS—head and neck cancer	0.000473	0.00121	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—STAT3—head and neck cancer	0.000473	0.00121	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—HRAS—head and neck cancer	0.000467	0.00119	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—DPYD—head and neck cancer	0.00046	0.00118	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—MAPK3—head and neck cancer	0.000452	0.00116	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IL2—head and neck cancer	0.000449	0.00115	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—AKT1—head and neck cancer	0.000448	0.00115	CbGpPWpGaD
Rifabutin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000439	0.00112	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—YAP1—head and neck cancer	0.000437	0.00112	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—MAPK1—head and neck cancer	0.00043	0.0011	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—GRP—head and neck cancer	0.000425	0.00109	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—PTEN—head and neck cancer	0.000422	0.00108	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—AKT1—head and neck cancer	0.000418	0.00107	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—STAT6—head and neck cancer	0.000413	0.00105	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—AKT1—head and neck cancer	0.000412	0.00105	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000407	0.00104	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—VEGFA—head and neck cancer	0.000406	0.00104	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CASP8—head and neck cancer	0.000398	0.00102	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—MAPK3—head and neck cancer	0.000384	0.000981	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—STAT3—head and neck cancer	0.000378	0.000965	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.000366	0.000936	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.000366	0.000936	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.000366	0.000936	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—YAP1—head and neck cancer	0.000365	0.000934	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—MAPK1—head and neck cancer	0.000365	0.000933	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—EGFR—head and neck cancer	0.000365	0.000933	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—TP53—head and neck cancer	0.000361	0.000923	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—MAPK3—head and neck cancer	0.000361	0.000922	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CCND1—head and neck cancer	0.000344	0.000879	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—MAPK1—head and neck cancer	0.000343	0.000878	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—EGFR—head and neck cancer	0.000343	0.000877	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—BCL2—head and neck cancer	0.000342	0.000873	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	0.000319	0.000815	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	0.000314	0.000804	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CCND1—head and neck cancer	0.000307	0.000786	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	0.000302	0.000773	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000298	0.000762	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—PIK3CA—head and neck cancer	0.000298	0.000762	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000294	0.000751	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—HRAS—head and neck cancer	0.000293	0.000749	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—VEGFA—head and neck cancer	0.000289	0.00074	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—STAT3—head and neck cancer	0.000287	0.000733	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—BCL2L1—head and neck cancer	0.000284	0.000725	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—MAPK3—head and neck cancer	0.000283	0.000725	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PTEN—head and neck cancer	0.000283	0.000724	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—HRAS—head and neck cancer	0.000276	0.000705	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MAPK3—head and neck cancer	0.000274	0.0007	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—MAPK1—head and neck cancer	0.00027	0.00069	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—UROD—head and neck cancer	0.000266	0.00068	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—TYMS—head and neck cancer	0.000262	0.00067	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MAPK1—head and neck cancer	0.00026	0.000666	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—EGFR—head and neck cancer	0.00026	0.000666	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GSTM1—head and neck cancer	0.000259	0.000663	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MAPK3—head and neck cancer	0.000253	0.000648	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GPX1—head and neck cancer	0.000248	0.000635	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000246	0.000629	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CYP1A1—head and neck cancer	0.000246	0.000628	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—AKT1—head and neck cancer	0.000243	0.000622	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000243	0.00062	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—MAPK3—head and neck cancer	0.000242	0.000618	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MAPK1—head and neck cancer	0.000241	0.000617	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NOTCH1—head and neck cancer	0.000235	0.000601	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000233	0.000596	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CASP8—head and neck cancer	0.000232	0.000593	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—MAPK1—head and neck cancer	0.00023	0.000588	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00023	0.000588	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—EGFR—head and neck cancer	0.00023	0.000588	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CDH1—head and neck cancer	0.000229	0.000586	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—HRAS—head and neck cancer	0.000209	0.000535	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000206	0.000527	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—UROD—head and neck cancer	0.000205	0.000525	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—TP53—head and neck cancer	0.000202	0.000518	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PIK3CA—head and neck cancer	0.0002	0.00051	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—BCL2—head and neck cancer	0.000199	0.000509	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—HRAS—head and neck cancer	0.000185	0.000472	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—AKT1—head and neck cancer	0.000185	0.000472	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL2—head and neck cancer	0.000175	0.000448	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTGS2—head and neck cancer	0.000174	0.000446	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PTEN—head and neck cancer	0.000165	0.000421	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NOTCH1—head and neck cancer	0.000165	0.000421	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—AKT1—head and neck cancer	0.000163	0.000417	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTEN—head and neck cancer	0.000152	0.000389	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—STAT3—head and neck cancer	0.000147	0.000377	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTGS2—head and neck cancer	0.000146	0.000374	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MAPK3—head and neck cancer	0.000141	0.00036	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—STAT3—head and neck cancer	0.000136	0.000348	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MAPK1—head and neck cancer	0.000134	0.000343	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—EGFR—head and neck cancer	0.000134	0.000343	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MAPK3—head and neck cancer	0.00013	0.000332	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTEN—head and neck cancer	0.000127	0.000326	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MAPK1—head and neck cancer	0.000124	0.000316	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—EGFR—head and neck cancer	0.000124	0.000316	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000117	0.0003	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PIK3CA—head and neck cancer	0.000116	0.000297	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000116	0.000297	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL2—head and neck cancer	0.000113	0.00029	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCND1—head and neck cancer	0.00011	0.000282	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NAT2—head and neck cancer	0.00011	0.000282	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HRAS—head and neck cancer	0.000108	0.000275	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PIK3CA—head and neck cancer	0.000107	0.000274	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PTEN—head and neck cancer	0.000107	0.000272	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HRAS—head and neck cancer	9.93e-05	0.000254	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—DPYD—head and neck cancer	9.68e-05	0.000247	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—VEGFA—head and neck cancer	9.62e-05	0.000246	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—STAT3—head and neck cancer	9.53e-05	0.000244	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—AKT1—head and neck cancer	9.5e-05	0.000243	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—YAP1—head and neck cancer	9.18e-05	0.000235	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MAPK3—head and neck cancer	9.1e-05	0.000233	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CA—head and neck cancer	8.99e-05	0.00023	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—AKT1—head and neck cancer	8.77e-05	0.000224	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MAPK1—head and neck cancer	8.66e-05	0.000222	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EGFR—head and neck cancer	8.66e-05	0.000221	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NAT2—head and neck cancer	8.52e-05	0.000218	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CA—head and neck cancer	7.52e-05	0.000192	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—DPYD—head and neck cancer	7.47e-05	0.000191	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—AKT1—head and neck cancer	7.34e-05	0.000188	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TP53—head and neck cancer	7.27e-05	0.000186	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—YAP1—head and neck cancer	7.09e-05	0.000181	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HRAS—head and neck cancer	6.95e-05	0.000178	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	6.9e-05	0.000176	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AKT1—head and neck cancer	6.14e-05	0.000157	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.02e-05	0.000154	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—TYMS—head and neck cancer	5.52e-05	0.000141	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTM1—head and neck cancer	5.45e-05	0.000139	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GPX1—head and neck cancer	5.22e-05	0.000133	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP1A1—head and neck cancer	5.17e-05	0.000132	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—TYMS—head and neck cancer	4.26e-05	0.000109	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.25e-05	0.000109	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTM1—head and neck cancer	4.21e-05	0.000108	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GPX1—head and neck cancer	4.03e-05	0.000103	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP1A1—head and neck cancer	3.99e-05	0.000102	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTGS2—head and neck cancer	3.07e-05	7.86e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTEN—head and neck cancer	2.68e-05	6.85e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTGS2—head and neck cancer	2.37e-05	6.07e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTEN—head and neck cancer	2.07e-05	5.29e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1.89e-05	4.84e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AKT1—head and neck cancer	1.54e-05	3.95e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.46e-05	3.73e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AKT1—head and neck cancer	1.19e-05	3.05e-05	CbGpPWpGaD
